Labshake search
Citations for Stemcell Technologies :
1 - 50 of 93 citations for 7 Benzoylheptanoic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2020Quote: ... After 72 hours the medium was replaced with 7 mL of neural differentiation medium supplemented with retinoic acid (RA) (Stemcell Technologies) at 0.25 nM and smoothened agonist (SAG ...
-
bioRxiv - Developmental Biology 2021Quote: ... Retinoic acid (Stemcell Technologies) at 0.25 nM and smoothened agonist (Stemcell Technologies ...
-
bioRxiv - Neuroscience 2023Quote: ... 200nM ascorbic acid (STEMCELL Technologies), 500 μg/ml cyclic AMP (SIGMA) ...
-
bioRxiv - Synthetic Biology 2023Quote: ... IL-7 (5 ng/mL) (Stemcell Technologies, Cat.#78053), IL-15 (5 ng/mL ...
-
bioRxiv - Neuroscience 2021Quote: ... 200 nM ascorbic acid (StemCell Technologies), 1x penicillin streptomycin (ThermoFisher ...
-
bioRxiv - Pathology 2022Quote: ... 200 µM Ascorbic Acid (StemCell Technologies), and 1µM Dibutyryl-cAMP (StemCell Technologies).
-
bioRxiv - Developmental Biology 2022Quote: ... supplemented with 7 μM CHIR 99021(STEMCELL Technologies, Catalog #72052) for 3 days ...
-
bioRxiv - Neuroscience 2021Quote: ... ascorbic acid (200 μM, #72132; StemCell Technologies), GDNF (20 ng/ml ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.2 M ascorbic acid (STEMCELL Technologies).
-
Prevention of tau accumulation through inhibition of hnRNP R-dependent axonal Mapt mRNA localizationbioRxiv - Neuroscience 2023Quote: ... 1 µM retinoic acid (72264, Stemcell Technologies) was added to the medium ...
-
bioRxiv - Neuroscience 2023Quote: ... non-essential amino acids (NEAA, Stemcell technologies). After 24h (day0) ...
-
bioRxiv - Biochemistry 2022Quote: ... 0.2 mM ascorbic acid (Stem cell technologies), 20ng/ml BDNF (Petrotech ...
-
bioRxiv - Molecular Biology 2019Quote: ... iPSCs were passaged every 5-7 days using ReLeSR (Stem Cell Technologies).
-
bioRxiv - Bioengineering 2021Quote: ... Cells were passaged every 6–7 days using Dispase (Stemcell Technologies, Canada). Differentiated colonies were removed manually by scraping ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 200 nM ascorbic acid (Stemcell Technologies,72132) till desired time ...
-
bioRxiv - Molecular Biology 2020Quote: ... using a working solution including 7 mL of Optiprep™ (#07820, Stemcell Technologies) with 1.4 mL of working buffer (0.25 M sucrose (200-334-9 ...
-
bioRxiv - Neuroscience 2019Quote: ... Cells were passaged by 7-min incubation with Dispase (STEMCELL Technologies, Vancouver, Canada). All hESCs have tested negative for mycoplasma.
-
bioRxiv - Developmental Biology 2024Quote: ... cells were split every 5-7 days with accutase (Stem Cell Technologies, #07920) (Bajpai et al. ...
-
Safety and efficacy of C9ORF72-repeat RNA nuclear export inhibition in amyotrophic lateral sclerosisbioRxiv - Systems Biology 2021Quote: ... All-Trans Retinoic Acid 0.1 µM (RA; StemCell Technologies) and Purmorphamine 0.5 µM (PMN ...
-
bioRxiv - Neuroscience 2022Quote: ... 3.52 μg/mL Ascorbic acid (Stem cell technologies # 72132), 0.5mM L-glutamine and 1% NEAA and then plated on to T25 flasks ...
-
bioRxiv - Molecular Biology 2022Quote: ... and 10 µM ascorbic acid (AA) (Stemcell Technologies 72132). Day 2 ...
-
bioRxiv - Neuroscience 2022Quote: ... Ascorbic acid (200 nM, Cat. No. 72132 STEMCELL Technologies), and laminin (1 μg/ml ...
-
bioRxiv - Cell Biology 2023Quote: ... and Am580 retinoic acid agonist 2.5 μM (STEMCELL Technologies) at 2 × 106 cells/mL density ...
-
bioRxiv - Neuroscience 2024Quote: ... and 200 nM Ascorbic Acid (#72132; Stem Cell Technology). From day 43 to 120 ...
-
bioRxiv - Neuroscience 2021Quote: ... iPSCs were fed daily and split every 4-7 days using ReLeSR (StemCell Technologies) according to manufacturer’s instructions ...
-
bioRxiv - Biochemistry 2022Quote: ... Cells were passaged every 5-7 days using ReLeSR (STEMCELL Technologies, Vancouver, BC, Canada) and maintained within passages 20 to 50.
-
bioRxiv - Cell Biology 2024Quote: ... They were grown for 3-7 days in BrainPhys basal media (#05790, Stemcell Technologies), supplemented with SM1 (#05711 ...
-
bioRxiv - Microbiology 2023Quote: ... ascorbic acid (50 μg/ml, STEMCELL Technologies, Cat# ST-72132), 1 × GlutaMAX (Thermo Fisher Scientific ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were passaged every 4 to 7 days with ReLeSR reagent (StemCell Technologies catalog #05872) to ensure that only undifferentiated stem cells remained in the cultures ...
-
bioRxiv - Bioengineering 2021Quote: ... then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 μM all-trans retinoic acid (RA, STEMCELL Technologies, 72262), and the removal of Glial Cell Derived Neurotrophic Factor (GDNF).
-
bioRxiv - Bioengineering 2021Quote: ... and 0.1 μM all-trans retinoic acid (Stem Cell Technologies; 72262) for 5 days ...
-
bioRxiv - Molecular Biology 2019Quote: ... and 10 µM all-trans retinoic acid (ATRA, Stemcell Technologies, 72264) (Differentiation Medium 1) ...
-
bioRxiv - Genomics 2020Quote: ... All-Trans Retinoic Acid 0.1 μM (RA, STEMCELL Technologies, Cat.: #72262), and Purmorphamine 0.5 μM (PMN ...
-
bioRxiv - Immunology 2021Quote: ... 50 μg/ml L-ascorbic acid (L-AA, Stem Cell Technologies) and 6 μg/ml holo-transferrin (Sigma) ...
-
bioRxiv - Immunology 2020Quote: ... Following enumeration using 3% acetic acid with methylene blue (StemCell Technologies), splenocytes were resuspended in phosphate-buffered saline and forty to sixty million cells were injected either intraperitoneally or intravenously (via retro-orbital injection under isoflurane anesthesia ...
-
bioRxiv - Neuroscience 2022Quote: ... iPSCs were passaged every 4 to 7 days with ReLeSR reagent (STEMCELL technologies catalog #100-0484) at a ratio of 1:6 per culture ...
-
bioRxiv - Bioengineering 2023Quote: ... Stages 3-7 used basal media of DMEM supplemented with BSA and SM1 (Stem Cell Technology) or B27 (ThermoFisher) ...
-
bioRxiv - Bioengineering 2021Quote: ... and then 1 µM all-trans retinoic acid (RA, STEMCELL Technologies, 72262) and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2 ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 % neomycin and addition of 10 μM retinoic acid (RA) (Stemcell Technologies). At day 6 the cells were washed twice with warm PBS (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2021Quote: ... Cultures were fed every other day and passaged every 5–7 days by ReLeSR™ (STEMCELL Technologies).
-
bioRxiv - Bioengineering 2023Quote: ... The iPSCs were routinely passaged every 5-7 days using ReLeSR™ Passaging Reagent (Stemcell Technologies, Canada). The iPSCs were then differentiated into SCPCs based on a modified protocol to generate spinal motor neurons (Hor et al. ...
-
bioRxiv - Neuroscience 2024Quote: ... embryonic bodies (EBs) were formed for 7 days in mTeSR plus medium in AggreWell plates (Stemcell Technologies) with addition of human recombinant BMP-4 (50 ng/ml ...
-
bioRxiv - Biochemistry 2023Quote: ... Cells were cultured for 7 d at 5% O2 in EpiCult- B mouse medium (STEMCELL Technologies, 05610) supplemented with 5% FBS ...
-
bioRxiv - Cancer Biology 2023Quote: ... for 5-7 days and embedded into 2 mg/ml collagen type-I (StemCell Technologies, Vancouver, Canada) gels ...
-
bioRxiv - Neuroscience 2020Quote: ... hiPSC colonies were passaged 1:6 every 4 to 7 days with Gentle Cell Dissociation Reagent (STEMCELL Technologies). Genomic integrity was validated by G-band karyotyping (Cell Line Genetics ...
-
bioRxiv - Developmental Biology 2020Quote: ... and pluripotent stem cells were passaged every 5 to 7 days in the ReLeSR medium (Stem Cell Technologies). Pluripotent iPSC and hESC were differentiated into retinal organoids as previously described (9 and Fig S1 ...
-
bioRxiv - Neuroscience 2022Quote: ... Cells were passaged in small aggregates (1:7/1:10 depending on the line) using ReLeSR (StemCell Technologies). 10 μM Y-27632 (ROCK inhibitor ...
-
bioRxiv - Neuroscience 2024Quote: ... hESCs were fed every two days and split every 4–7 days using ReLeSR (StemCell Technologies, 100-0483) according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2019Quote: ... and cultured at 37°C (5% CO2) for 7 days in 300 µL StemSpan™ SFEM (#09650 Stemcell Technologies) supplemented with 100 ng/mL SCF (Peprotech ...